Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$810.84B | 38.5x | 1.01 | US$101.70 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.8% Upside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$43.98B | 16.9x | 6.02 | US$66.36 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$39.82B | 22.3x | -5.21 | US$83.27 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$39.39B | 19.6x | 0.43 | US$18.41 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$39.39B | 19.6x | 0.43 | US$6.05 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$36.25B | 17x | 5.54 | US$40.27 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.9% Upside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$36.25B | 17x | 5.49 | US$39 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.47B | 25.5x | US$13.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.47B | 25.5x | US$13.14 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$31.02B | 34.3x | -1.34 | US$96.32 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$30.97B | 241.7x | -6.12 | US$11.90 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$20.87B | 36x | 2.6 | US$561.40 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.7% Upside | Upgrade to Pro+ | |
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$17B | 32.5x | 2.88 | US$75.51 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.03B | 46.8x | -2.19 | US$102.43 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.13B | 20.9x | -3.76 | US$47.94 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.4% Upside | Upgrade to Pro+ | |
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.71B | 16.8x | 0.76 | US$13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$12.66B | 21.4x | 0.25 | US$39.48 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.69B | 27.1x | 2.45 | US$11.95 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.80B | 26.5x | -0.45 | US$3.11 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.6% Downside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.29B | 21.9x | 0.42 | US$105.31 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.10B | 18.7x | 0.23 | US$18.22 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.5% Downside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.97B | 26.3x | -0.75 | US$4.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.97B | 26.3x | -0.74 | US$9.91 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.70B | 10.6x | -0.7 | US$17.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.69B | 20.4x | 0.91 | US$16.14 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.43B | 19.1x | -1.63 | US$10.49 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.78B | 24.4x | 1.25 | US$3.29 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clicks Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.88B | 28x | 1.98 | US$40.86 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.60B | 12x | -0.18 | US$9.45 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DFI Retail Holdings DRC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.56B | -12.1x | 0.03 | US$15.92 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BBB Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.93B | -392.6x | -6.84 | US$25.12 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.6% Upside | Upgrade to Pro+ | |
United Natural Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.43B | -20.2x | -0.53 | US$40.04 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.9% Downside | Upgrade to Pro+ | |
Sendas Distribuidora | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.34B | 68.2x | 0.35 | US$8.69 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Sun Art Retail ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.27B | 42.3x | 0.33 | US$2.20 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Chefs Warehouse | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.25B | 33.9x | 0.54 | US$55.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.9% Upside | Upgrade to Pro+ | |
Green Thumb Industries | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2B | 71.2x | -0.97 | US$8.73 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vital Farms | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.84B | 36.6x | 6.82 | US$41.21 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
Weis Markets | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.77B | 17.8x | 1.05 | US$71.57 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grocery Outlet | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.59B | 193.4x | -2.26 | US$16.18 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Guardian Pharmacy Services | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.55B | -17.3x | US$24.42 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | ||
Ingles | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.33B | 23.6x | -0.36 | US$70.22 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hellofresh | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.28B | -6.8x | 0.09 | US$8.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pick N Pay ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.07B | -22.7x | US$7.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Verano Holdings | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$556.98M | -1.5x | 0.01 | US$1.55 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Village Super Market | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$543.31M | 9.7x | 0.82 | US$36.82 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$320.37M | -3x | 0.07 | US$0.89 | 12.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$314.31M | -41.3x | -0.64 | US$3.60 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
G Willi-Food | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$270.43M | 9.2x | 0.07 | US$19.48 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Epsium Enterprise | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$202.65M | 572x | -18.55 | US$15.08 | 30.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hf Foods | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$149.63M | -3x | 0 | US$2.72 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |